ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Liver Failure Therapeutics Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-6E14125
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Liver Failure Therapeutics Market Insights Forecast to 2029
BUY CHAPTERS

Global Liver Failure Therapeutics Market Research Report 2025

Code: QYRE-Auto-6E14125
Report
January 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc

Liver Failure Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liver Failure Therapeutics Market

Liver Failure Therapeutics Market

The global market for Liver Failure Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liver Failure Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Failure Therapeutics.
The Liver Failure Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liver Failure Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liver Failure Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Liver Failure Therapeutics Market Report

Report Metric Details
Report Name Liver Failure Therapeutics Market
CAGR 5%
Segment by Type
  • Ornithine Phenylacetate
  • MTL-CEBPA
  • F-573
  • BL-1220
  • PP-100
  • Others
Segment by Application
  • Clinic
  • Hospital
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alfact Innovation, BioLineRx Ltd, Cell2B Advanced Therapeutics SA, Conatus Pharmaceuticals Inc, Immune Pharmaceuticals Inc, Mina Therapeutics Ltd, Mylan NV, Ocera Therapeutics Inc, PledPharma AB, Promethera Biosciences SA, Silence Therapeutics Plc, Unicyte AG, Ventria Bioscience, Vital Therapies Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Liver Failure Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liver Failure Therapeutics Market report?

Ans: The main players in the Liver Failure Therapeutics Market are Alfact Innovation, BioLineRx Ltd, Cell2B Advanced Therapeutics SA, Conatus Pharmaceuticals Inc, Immune Pharmaceuticals Inc, Mina Therapeutics Ltd, Mylan NV, Ocera Therapeutics Inc, PledPharma AB, Promethera Biosciences SA, Silence Therapeutics Plc, Unicyte AG, Ventria Bioscience, Vital Therapies Inc

What are the Application segmentation covered in the Liver Failure Therapeutics Market report?

Ans: The Applications covered in the Liver Failure Therapeutics Market report are Clinic, Hospital, Others

What are the Type segmentation covered in the Liver Failure Therapeutics Market report?

Ans: The Types covered in the Liver Failure Therapeutics Market report are Ornithine Phenylacetate, MTL-CEBPA, F-573, BL-1220, PP-100, Others

Recommended Reports

Liver and Organ Disease

Therapeutics and Drugs

Diagnostics and Monitoring

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Market by Application
1.3.1 Global Liver Failure Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Failure Therapeutics Market Perspective (2020-2031)
2.2 Global Liver Failure Therapeutics Growth Trends by Region
2.2.1 Global Liver Failure Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Liver Failure Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Liver Failure Therapeutics Market Dynamics
2.3.1 Liver Failure Therapeutics Industry Trends
2.3.2 Liver Failure Therapeutics Market Drivers
2.3.3 Liver Failure Therapeutics Market Challenges
2.3.4 Liver Failure Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Revenue
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Liver Failure Therapeutics Revenue
3.4 Global Liver Failure Therapeutics Market Concentration Ratio
3.4.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2024
3.5 Global Key Players of Liver Failure Therapeutics Head office and Area Served
3.6 Global Key Players of Liver Failure Therapeutics, Product and Application
3.7 Global Key Players of Liver Failure Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Failure Therapeutics Breakdown Data by Type
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2026-2031)
5 Liver Failure Therapeutics Breakdown Data by Application
5.1 Global Liver Failure Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Liver Failure Therapeutics Market Size (2020-2031)
6.2 North America Liver Failure Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Liver Failure Therapeutics Market Size by Country (2020-2025)
6.4 North America Liver Failure Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2020-2031)
7.2 Europe Liver Failure Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Liver Failure Therapeutics Market Size by Country (2020-2025)
7.4 Europe Liver Failure Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Failure Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Liver Failure Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Failure Therapeutics Market Size (2020-2031)
9.2 Latin America Liver Failure Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Liver Failure Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Liver Failure Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Failure Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Liver Failure Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Company Details
11.1.2 Alfact Innovation Business Overview
11.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
11.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2020-2025)
11.1.5 Alfact Innovation Recent Development
11.2 BioLineRx Ltd
11.2.1 BioLineRx Ltd Company Details
11.2.2 BioLineRx Ltd Business Overview
11.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
11.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2020-2025)
11.2.5 BioLineRx Ltd Recent Development
11.3 Cell2B Advanced Therapeutics SA
11.3.1 Cell2B Advanced Therapeutics SA Company Details
11.3.2 Cell2B Advanced Therapeutics SA Business Overview
11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
11.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2020-2025)
11.3.5 Cell2B Advanced Therapeutics SA Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Details
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2020-2025)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Details
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2020-2025)
11.5.5 Immune Pharmaceuticals Inc Recent Development
11.6 Mina Therapeutics Ltd
11.6.1 Mina Therapeutics Ltd Company Details
11.6.2 Mina Therapeutics Ltd Business Overview
11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
11.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2020-2025)
11.6.5 Mina Therapeutics Ltd Recent Development
11.7 Mylan NV
11.7.1 Mylan NV Company Details
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Liver Failure Therapeutics Introduction
11.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2020-2025)
11.7.5 Mylan NV Recent Development
11.8 Ocera Therapeutics Inc
11.8.1 Ocera Therapeutics Inc Company Details
11.8.2 Ocera Therapeutics Inc Business Overview
11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
11.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2020-2025)
11.8.5 Ocera Therapeutics Inc Recent Development
11.9 PledPharma AB
11.9.1 PledPharma AB Company Details
11.9.2 PledPharma AB Business Overview
11.9.3 PledPharma AB Liver Failure Therapeutics Introduction
11.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2020-2025)
11.9.5 PledPharma AB Recent Development
11.10 Promethera Biosciences SA
11.10.1 Promethera Biosciences SA Company Details
11.10.2 Promethera Biosciences SA Business Overview
11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
11.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2020-2025)
11.10.5 Promethera Biosciences SA Recent Development
11.11 Silence Therapeutics Plc
11.11.1 Silence Therapeutics Plc Company Details
11.11.2 Silence Therapeutics Plc Business Overview
11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
11.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2020-2025)
11.11.5 Silence Therapeutics Plc Recent Development
11.12 Unicyte AG
11.12.1 Unicyte AG Company Details
11.12.2 Unicyte AG Business Overview
11.12.3 Unicyte AG Liver Failure Therapeutics Introduction
11.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2020-2025)
11.12.5 Unicyte AG Recent Development
11.13 Ventria Bioscience
11.13.1 Ventria Bioscience Company Details
11.13.2 Ventria Bioscience Business Overview
11.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
11.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2020-2025)
11.13.5 Ventria Bioscience Recent Development
11.14 Vital Therapies Inc
11.14.1 Vital Therapies Inc Company Details
11.14.2 Vital Therapies Inc Business Overview
11.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
11.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2020-2025)
11.14.5 Vital Therapies Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Alfact Innovation
BioLineRx Ltd
Cell2B Advanced Therapeutics SA
Conatus Pharmaceuticals Inc
Immune Pharmaceuticals Inc
Mina Therapeutics Ltd
Mylan NV
Ocera Therapeutics Inc
PledPharma
Promethera Biosciences SA
Silence Therapeutics Plc
Unicyte AG
Ventria Bioscience
Vital Therapies Inc
List of Tables
 Table 1. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ornithine Phenylacetate
 Table 3. Key Players of MTL-CEBPA
 Table 4. Key Players of F-573
 Table 5. Key Players of BL-1220
 Table 6. Key Players of PP-100
 Table 7. Key Players of Others
 Table 8. Global Liver Failure Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Liver Failure Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Liver Failure Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Liver Failure Therapeutics Market Share by Region (2020-2025)
 Table 12. Global Liver Failure Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Liver Failure Therapeutics Market Share by Region (2026-2031)
 Table 14. Liver Failure Therapeutics Market Trends
 Table 15. Liver Failure Therapeutics Market Drivers
 Table 16. Liver Failure Therapeutics Market Challenges
 Table 17. Liver Failure Therapeutics Market Restraints
 Table 18. Global Liver Failure Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Liver Failure Therapeutics Market Share by Players (2020-2025)
 Table 20. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2024)
 Table 21. Ranking of Global Top Liver Failure Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Liver Failure Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Liver Failure Therapeutics, Headquarters and Area Served
 Table 24. Global Key Players of Liver Failure Therapeutics, Product and Application
 Table 25. Global Key Players of Liver Failure Therapeutics, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Liver Failure Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Liver Failure Therapeutics Revenue Market Share by Type (2020-2025)
 Table 29. Global Liver Failure Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Liver Failure Therapeutics Revenue Market Share by Type (2026-2031)
 Table 31. Global Liver Failure Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Liver Failure Therapeutics Revenue Market Share by Application (2020-2025)
 Table 33. Global Liver Failure Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Liver Failure Therapeutics Revenue Market Share by Application (2026-2031)
 Table 35. North America Liver Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Liver Failure Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Liver Failure Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Liver Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Liver Failure Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Liver Failure Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Liver Failure Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Liver Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Liver Failure Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Liver Failure Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Liver Failure Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Alfact Innovation Company Details
 Table 51. Alfact Innovation Business Overview
 Table 52. Alfact Innovation Liver Failure Therapeutics Product
 Table 53. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 54. Alfact Innovation Recent Development
 Table 55. BioLineRx Ltd Company Details
 Table 56. BioLineRx Ltd Business Overview
 Table 57. BioLineRx Ltd Liver Failure Therapeutics Product
 Table 58. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 59. BioLineRx Ltd Recent Development
 Table 60. Cell2B Advanced Therapeutics SA Company Details
 Table 61. Cell2B Advanced Therapeutics SA Business Overview
 Table 62. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product
 Table 63. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 64. Cell2B Advanced Therapeutics SA Recent Development
 Table 65. Conatus Pharmaceuticals Inc Company Details
 Table 66. Conatus Pharmaceuticals Inc Business Overview
 Table 67. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product
 Table 68. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 69. Conatus Pharmaceuticals Inc Recent Development
 Table 70. Immune Pharmaceuticals Inc Company Details
 Table 71. Immune Pharmaceuticals Inc Business Overview
 Table 72. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product
 Table 73. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 74. Immune Pharmaceuticals Inc Recent Development
 Table 75. Mina Therapeutics Ltd Company Details
 Table 76. Mina Therapeutics Ltd Business Overview
 Table 77. Mina Therapeutics Ltd Liver Failure Therapeutics Product
 Table 78. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 79. Mina Therapeutics Ltd Recent Development
 Table 80. Mylan NV Company Details
 Table 81. Mylan NV Business Overview
 Table 82. Mylan NV Liver Failure Therapeutics Product
 Table 83. Mylan NV Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 84. Mylan NV Recent Development
 Table 85. Ocera Therapeutics Inc Company Details
 Table 86. Ocera Therapeutics Inc Business Overview
 Table 87. Ocera Therapeutics Inc Liver Failure Therapeutics Product
 Table 88. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 89. Ocera Therapeutics Inc Recent Development
 Table 90. PledPharma AB Company Details
 Table 91. PledPharma AB Business Overview
 Table 92. PledPharma AB Liver Failure Therapeutics Product
 Table 93. PledPharma AB Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 94. PledPharma AB Recent Development
 Table 95. Promethera Biosciences SA Company Details
 Table 96. Promethera Biosciences SA Business Overview
 Table 97. Promethera Biosciences SA Liver Failure Therapeutics Product
 Table 98. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 99. Promethera Biosciences SA Recent Development
 Table 100. Silence Therapeutics Plc Company Details
 Table 101. Silence Therapeutics Plc Business Overview
 Table 102. Silence Therapeutics Plc Liver Failure Therapeutics Product
 Table 103. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 104. Silence Therapeutics Plc Recent Development
 Table 105. Unicyte AG Company Details
 Table 106. Unicyte AG Business Overview
 Table 107. Unicyte AG Liver Failure Therapeutics Product
 Table 108. Unicyte AG Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 109. Unicyte AG Recent Development
 Table 110. Ventria Bioscience Company Details
 Table 111. Ventria Bioscience Business Overview
 Table 112. Ventria Bioscience Liver Failure Therapeutics Product
 Table 113. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 114. Ventria Bioscience Recent Development
 Table 115. Vital Therapies Inc Company Details
 Table 116. Vital Therapies Inc Business Overview
 Table 117. Vital Therapies Inc Liver Failure Therapeutics Product
 Table 118. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2020-2025) & (US$ Million)
 Table 119. Vital Therapies Inc Recent Development
 Table 120. Research Programs/Design for This Report
 Table 121. Key Data Information from Secondary Sources
 Table 122. Key Data Information from Primary Sources
 Table 123. Authors List of This Report


List of Figures
 Figure 1. Liver Failure Therapeutics Picture
 Figure 2. Global Liver Failure Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Liver Failure Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Ornithine Phenylacetate Features
 Figure 5. MTL-CEBPA Features
 Figure 6. F-573 Features
 Figure 7. BL-1220 Features
 Figure 8. PP-100 Features
 Figure 9. Others Features
 Figure 10. Global Liver Failure Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Liver Failure Therapeutics Market Share by Application: 2024 VS 2031
 Figure 12. Clinic Case Studies
 Figure 13. Hospital Case Studies
 Figure 14. Others Case Studies
 Figure 15. Liver Failure Therapeutics Report Years Considered
 Figure 16. Global Liver Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Liver Failure Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Liver Failure Therapeutics Market Share by Region: 2024 VS 2031
 Figure 19. Global Liver Failure Therapeutics Market Share by Players in 2024
 Figure 20. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Failure Therapeutics as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2024
 Figure 22. North America Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Liver Failure Therapeutics Market Share by Country (2020-2031)
 Figure 24. United States Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Liver Failure Therapeutics Market Share by Country (2020-2031)
 Figure 28. Germany Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Liver Failure Therapeutics Market Share by Region (2020-2031)
 Figure 36. China Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Liver Failure Therapeutics Market Share by Country (2020-2031)
 Figure 44. Mexico Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Liver Failure Therapeutics Market Share by Country (2020-2031)
 Figure 48. Turkey Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Liver Failure Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 52. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 53. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 54. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 55. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 56. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 57. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 58. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 59. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 60. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 61. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 62. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 63. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 64. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cirrhosis Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cancer Treatment Drug Market Research Report 2025
Chronic Liver Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alcoholic Hepatiti Drug Market Research Report 2024
Global Hepatic Encephalopathy Drug Market Research Report 2024
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatitis C Virus Drugs Market Research Report 2025
Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024
Global Alcohol Addiction Therapeutics Market Research Report 2024
Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adult Chronic Hepatitis B Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hepatitis B Virus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Critical Care Therapeutics Market Research Report 2025
Global Primary Biliary Cirrhosis Drug Market Research Report 2024
Global Unresectable Hepatocellular Carcinoma Treatment Market Research Report 2024
Global Anti HBV Drugs Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Chronic Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions